SFRS15, or SCAF4, plays a pivotal role in RNA processing, particularly in spliceosome dynamics. The complexities and multifaceted nature of RNA splicing necessitate a vast signaling network. Several chemicals are known to influence various cellular pathways that could intersect with or modulate the activity and function of SFRS15.
Forskolin, a chemical that elevates intracellular cAMP levels, and Isoproterenol, a β-adrenergic receptor agonist, both target cAMP pathways that could be related to the functionalities of SFRS15 within cells. Similarly, Lithium chloride activates the Wnt signaling pathway, a process potentially engaged with SFRS15 actions. Chemicals like LY294002 and Wortmannin, both inhibitors of PI3K, show a potential relationship between the PI3K/AKT pathway and SFRS15's cellular tasks. Another noteworthy compound is Rapamycin, an mTOR inhibitor, suggesting its potential intersection with protein synthesis processes that SFRS15 might be involved in. PMA, an activator of Protein Kinase C (PKC), further illustrates the breadth of cellular signaling that SFRS15 might be associated with.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, which can influence SFRS15 activity through related signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Can activate the Wnt signaling pathway, which may be relevant to the SFRS15 function in cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can modulate the MAPK/ERK pathway, potentially impacting SFRS15's role. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
CDK inhibitor affecting cell cycle processes, which might be relevant to SFRS15's functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; its modulation of the PI3K/AKT pathway may be related to SFRS15's cellular activities. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC); can influence pathways where SFRS15 is involved. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; affects cellular growth and protein synthesis pathways that can be relevant to SFRS15. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor; its effect on cytoskeletal dynamics can intersect with pathways where SFRS15 operates. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
β-adrenergic receptor agonist; can modulate cAMP pathways, potentially influencing SFRS15. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor; its effect on the PI3K/AKT signaling pathway can be relevant to SFRS15's cellular role. | ||||||